Why it matters: More than 3.5 million Californians have diabetes, and insulin is a life-saving part of their disease ...

During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...

Novo Nordisk launched "My Ozempic ®  Era" today, a national campaign which spotlights the longstanding Ozempic ®  patient ...

On Monday, the company reported a 3.2% increase in first-half net income to R2.39bn. Aspen Pharmacare’s profit climbed after ...

Type 1 Diabetes Market Rising Prevalence and Technological Advancements Drive Market Growth AUSTIN, TX, UNITED STATES, February 28, 202 ...

Embecta's compelling ~44% free cash flow yield offers a strong risk-reward despite headwinds from new insulin technologies ...

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.

Cash position of €7.5 million as of December 31, 2024 BioChaperone Lispro final dosing of Phase 3 triggered a $10 million revenue recognition, and top-line data are expected in mid-2025 ...

WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...

Market OverviewThe Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value ...